Information Provided By:
Fly News Breaks for July 29, 2016
ALKS
Jul 29, 2016 | 08:46 EDT
Cowen said the weakness in Alkermes is a buying opportunity as they believe the magnitude, sustainability, and impact of Vivitrol's growth is being meaningfully underestimated by the Street. Cowen reiterated its Outperform rating and $60 price target on Alkermes shares.
News For ALKS From the Last 2 Days
There are no results for your query ALKS